Talaris Therapeutics
TALS
#8572
Rank
C$0.16 B
Marketcap
$3.78
Share price
-0.73%
Change (1 day)
74.48%
Change (1 year)

Revenue for Talaris Therapeutics (TALS)

Revenue in 2023 (TTM): N/A

In 2022 the company made a revenue of N/A a decrease over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Talaris Therapeutics from 2020 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) N/A
2022 N/A
2021 N/A
2020 N/A